Schwann cell-specific PTEN and EGFR dysfunctions affect neuromuscular junction development by impairing Agrin signaling and autophagy

Biochem Biophys Res Commun. 2019 Jul 12;515(1):50-56. doi: 10.1016/j.bbrc.2019.05.014. Epub 2019 May 21.

Abstract

The neuromuscular junction (NMJ) is formed by motor nerve terminals, post-junctional muscle membranes, and terminal Schwann cells (SCs). The formation of NMJ requires complex and dynamic molecular interactions. Nerve- and muscle-derived molecules have been well characterized but the mechanistic involvement of SC in NMJ development remains poorly understood. SC-specific phosphatase and tensin homolog (Pten) inactivation and epidermal growth factor receptor (EGFR) overexpression (Dhh-Cre; Cnp-EGFR; Ptenflox/flox or DET) mice were used and NMJ malformation was observed in these mice. Acetylcholine receptors (AChRs) were distorted and varicose presynaptic nerve terminals appeared in the tibialis anterior (TA) muscle of DET mice. Agrin signaling related to NMJ development, was downregulated in TA muscle. Both RAS/MEK/ERK and PI3K/AKT/mTOR signaling pathways were activated in the sciatic nerves of DET mice. In addition, autophagy was downregulated in these sciatic nerves. Interestingly, the use of Torin 2, an mTOR inhibitor, rescued the phenotype. The downregulated-autophagy might account for Agrin signaling abnormity, which induced NMJ malformation. Taken together, our results indicate that SCs-specific Pten and EGFR cooperation are essential for NMJ development.

Keywords: EGFR; Neuromuscular junction; Pten; Schwann cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agrin / metabolism*
  • Animals
  • Autophagy*
  • ErbB Receptors / metabolism*
  • Female
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Naphthyridines / pharmacology
  • Neuromuscular Junction / drug effects
  • Neuromuscular Junction / metabolism*
  • Neuromuscular Junction / pathology*
  • PTEN Phosphohydrolase / metabolism*
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / metabolism
  • Receptors, Cholinergic / metabolism
  • Schwann Cells / drug effects
  • Schwann Cells / metabolism*
  • Schwann Cells / pathology
  • Sciatic Nerve / drug effects
  • Sciatic Nerve / metabolism
  • Signal Transduction* / drug effects
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one
  • Agrin
  • Naphthyridines
  • Receptors, Cholinergic
  • mTOR protein, mouse
  • EGFR protein, mouse
  • ErbB Receptors
  • TOR Serine-Threonine Kinases
  • PTEN Phosphohydrolase
  • Pten protein, mouse